Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MBX Biosciences (MBX) Other Operating Expenses (2024 - 2025)

MBX Biosciences has reported Other Operating Expenses over the past 2 years, most recently at -$21.6 million for Q3 2025.

  • Quarterly results put Other Operating Expenses at -$21.6 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Mar 2026 was -$41.7 million (up 28.72% YoY), and the annual figure for FY2024 was -$63.7 million, changed.
  • Other Operating Expenses reached -$21.6 million in Q3 2025 per MBX's latest filing, down from -$20.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at -$12.0 million in Q1 2024 and bottomed at -$25.1 million in Q1 2025.